Literature DB >> 8854819

[Study of hepatic arterial chemoinfusion with continuous CDDP, 5-FU low dose administration for advanced gallbladder cancer].

S Fukuda1, K Okuda, H Kinoshita, T Nakayama, M Tanaka, T Yoshida, H Isomoto.   

Abstract

Eight unresectable cases of gallbladder cancer underwent hepatic-artery infusion (HAI) with a consequent combination of cisplatin (CDDP) and 5-fluorouracil (5-FU) administration at a continuous low dose. Five cases (62.5%) showed a partial response (PR). Median survival time was 481.9 days. Cytoreductive surgery was performed in three patients of PR. One case has been disease free and alive over 52 months postoperatively. Gallbladder cancer is well known as a chemoresistant cancer, whereas the higher response rate and the longer survival were achieved with HAI. These results suggested CDDP, 5-FU HAI is a useful chemotherapy for advanced gallbladder cancer, and it is also worthwhile to introduce the preoperative down-staging for consequent cytoreduction surgery.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8854819

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  Advanced gallbladder carcinoma with liver metastasis showing a favorable response after intra-arterial infusion chemotherapy: report of a case.

Authors:  H Hara; E Nomura; I Watanabe; S Sako; M Otani; N Tanigawa
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Microscopic liver metastasis: prognostic factor for patients with pT2 gallbladder carcinoma.

Authors:  Itaru Endo; Hiroshi Shimada; Atsushi Takimoto; Yoshiro Fujii; Yasuhiko Miura; Mitsutaka Sugita; Daisuke Morioka; Hideki Masunari; Kuniya Tanaka; Hitoshi Sekido; Shinji Togo
Journal:  World J Surg       Date:  2004-06-04       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.